PMDA to Make Public Adverse Reactions Reported by Patients by Year-End

The Pharmaceuticals and Medical Devices Agency (PMDA) is set to revamp a trial service to accept adverse reaction reports from patients in preparation for its full launch, planning to make public the reported side effects by the end of the...read more